Food or nutrient restriction offers insight into cancer prevention and metabolic disease

November 16, 2016

Could limiting food intake be a valid treatment strategy for certain types of cancers? New research in The FASEB Journal suggests "maybe." In a report appearing online in The FASEB Journal, scientists show that food restriction increases levels of a tumor-suppressing molecule, called p53, in both hepatocytes grown in the laboratory and in mouse liver. In addition, this research gives evidence that p53-induction is required for the fasting-induced adaptation of nutrient metabolism.

"Metabolic diseases and cancer are major health burdens in our societies," said Andreas Prokesch, Ph.D., study author and Associate Professor at the Institute of Cell Biology, Histology, and Embryology at the Medical University of Graz in Graz, Austria. "We hope that our study will yield new therapeutic concepts to fight these diseases."

To make their discovery, Prokesch and colleagues first determined the abundance of p53 protein in the livers of mice with free access to food compared to mice that had food withheld for 24 hours. They found that there was a strong induction of p53 protein in the livers of the mice that had undergone food withdrawal. This p53 accumulation was also observed in cultured mouse or human hepatocytes upon the removal of nutrients from their culture media. The researchers then compared blood glucose and amino acid utilization in the livers of mice with or without acute inactivation of the p53 gene. Mice that lacked p53 in the liver showed reduced blood glucose levels and altered hepatic amino acid metabolism during starvation.

"Connections between nutrients and tumor suppression have long been known, but this study adds a sharp focal point," said Thoru Pederson, Ph.D., Editor-in-Chief of The FASEB Journal. "The altered amino acid metabolism observed is especially provocative, as that is a rapidly emerging area of interest in tumor biochemistry."
-end-
Submit to The FASEB Journal by visiting http://fasebj.msubmit.net, and receive monthly highlights by signing up at http://www.faseb.org/fjupdate.aspx. The FASEB Journal is published by the Federation of the American Societies for Experimental Biology (FASEB). It is the world's most cited biology journal according to the Institute for Scientific Information and has been recognized by the Special Libraries Association as one of the top 100 most influential biomedical journals of the past century.

FASEB is composed of 30 societies with more than 125,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.

Details: Andreas Prokesch, Franziska A. Graef, Tobias Madl, Jennifer Kahlhofer, Steffi Heidenreich, Anne Schumann, Elisabeth Moyschewitz, Petra Pristoynik, Astrid Blaschitz, Miriam Knauer, Matthias Muenzner, Juliane G. Bogner-Strauss, Gottfried Dohr, Tim J. Schulz, and Michael Schupp. Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis. FASEB J. doi:10.1096/fj.201600845R ; http://www.fasebj.org/content/early/2016/11/06/fj.201600845R.abstract

Federation of American Societies for Experimental Biology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.